• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Spain

An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background
Manufacturing

Artis BioSolutions expands next-gen genetic medicines production

Artis BioSolutions opened a new manufacturing center located in Spain, expanding its production capabilities in next-generation genetic medicines.
Joseph Keenan Aug 27, 2026 8:45am
AZ

AZ taps Spain head Rick Suarez to lead US investment surge

Jan 8, 2026 10:40am
Novo Nordisk

Novo Nordisk questioned over Spanish obesity awareness campaign

Jun 25, 2025 10:05am
financials earnings profit profit miss earnings miss decline revenue decline

Rovi warns analyst profit consensus is 10% to 15% too high

Feb 13, 2025 9:58am
turning down money rejecting money business offer

Grifols deflects private equity firm's potential takeover offer

Nov 20, 2024 10:13am
deal handshake business cooperation partnerships

Teva inks cancer biosimilar marketing pact with mAbxience

Apr 4, 2024 10:33am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings